Plain-English translation of NCT06329622 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a medication called Ketosteril can help people with chronic kidney disease (stages 3–4) rebuild muscle mass and strength. Sarcopenia—the medical term for age-related muscle loss—is common in kidney disease patients and makes daily life harder. Researchers want to see if the medication, combined with a carefully controlled low-protein diet, can improve muscle without harming the kidneys further.
People with chronic kidney disease often lose muscle mass, which makes them weaker and less able to do everyday activities. Currently, doctors recommend a low-protein diet to protect the kidneys, but this diet alone may not be enough to prevent or reverse muscle loss. This trial is testing whether adding this medication to the diet can safely help patients regain strength and function.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of two groups for 9 months. One group will take Ketosteril along with a low-protein diet; the other group will follow the low-protein diet alone. Both groups will need to stick to specific amounts of protein and calories each day. You will likely have regular check-ins to monitor your kidney function, muscle strength, and overall health throughout the study.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
China